|
MPS Pharma Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
3.36 Cr.
|
P/BV
|
3.12
|
Book Value (Rs.)
|
0.57
|
|
52 Week High/Low (Rs.)
|
4/2
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
28/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Employees Cost | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Other Expenses | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Total Expenses | 0.23 | 0.23 | 0.23 | 0.22 | 0.23 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.23 | -0.23 | -0.23 | -0.22 | -0.23 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 |
| P/L Before Interest, Excpt. Items & Tax | -0.23 | -0.23 | -0.23 | -0.18 | -0.23 |
| P/L Before Exceptional Items & Tax | -0.23 | -0.23 | -0.23 | -0.18 | -0.23 |
| P/L Before Tax | -0.23 | -0.23 | -0.23 | -0.18 | -0.23 |
| Tax | -0.01 | -0.01 | 0.05 | 0.00 | -0.01 |
| P/L After Tax from Ordinary Activities | -0.22 | -0.22 | -0.28 | -0.17 | -0.22 |
| Net Profit/Loss For the Period | -0.22 | -0.22 | -0.28 | -0.17 | -0.22 |
| | | | | | |
| Equity Share Capital | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.12 | -0.12 | -0.15 | -0.09 | -0.12 |
| Diluted EPS (Rs.) | -0.12 | -0.12 | -0.15 | -0.09 | -0.12 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.12 | -0.12 | -0.15 | -0.09 | -0.12 |
| Diluted EPS (Rs.) | -0.12 | -0.12 | -0.15 | -0.09 | -0.12 |
